We are live on
!
Find out more
MB
MPM BioImpact Portfolio holdings
AUM
$1.29B
1-Year Est. Return
141.72%
This Fund
S&P 500
This Quarter
Est. Return
+44.98%
1 Year Est. Return
+141.72%
3 Year Est. Return
+440.65%
5 Year Est. Return
+290.21%
10 Year Est. Return
–
AUM
$874M
AUM Growth
+$263M
(+43%)
Cap. Flow
+$99.1M
Cap. Flow
% of AUM
11.34%
Top 10 Holdings %
Top 10 Hldgs %
49.85%
Holding
55
New
15
Increased
6
Reduced
16
Closed
17
Top Buys
| 1 |
uniQure
QURE
|
+$53.3M |
| 2 |
Agios Pharmaceuticals
AGIO
|
+$45.7M |
| 3 |
Liquidia Corp
LQDA
|
+$34.2M |
| 4 |
Corvus Pharmaceuticals
CRVS
|
+$21.6M |
| 5 |
UroGen Pharma
URGN
|
+$17.5M |
Top Sells
| 1 |
RNAM
Avidity Biosciences
RNAM
|
+$33.1M |
| 2 |
Zai Lab
ZLAB
|
+$25.3M |
| 3 |
Compass Therapeutics
CMPX
|
+$17.8M |
| 4 |
Alkermes
ALKS
|
+$16.5M |
| 5 |
Vera Therapeutics
VERA
|
+$16.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
ARS Pharmaceuticals
SPRY
$739M
| – | – |
-1,303,399
| Closed | -$13.1M |
|
|
52
Vera Therapeutics
VERA
$3.07B
| – | – |
-563,075
| Closed | -$16.4M |
|
53
Wave Life Sciences
WVE
$1.14B
| – | – |
-1,505,262
| Closed | -$11M |
|
|
54
Zai Lab
ZLAB
$2.29B
| – | – |
-745,060
| Closed | -$25.3M |
|
|
RAPP
55
Rapport Therapeutics
RAPP
$1.92B
| – | – |
-71,807
| Closed | -$2.13M |
|
Similar funds
MCM
PWP
ACM
GPCM
ACM
PCM
COCM
MA